Meeting of the European Task Group
for Endocrine Cancers - ESE Special Interest Group
“Endocrine cancers and endocrine oncology”
May 28th, 2016, Munich, Germany
Holiday Inn Munich – City Centre, Hochstrasse 3, D-81669 Munich
08:30 – 08:45 Welcome and coffee
08:45 – 09:00 Information on the activity and goals of ETEC
Barbara Jarząb, Poland
09:00 – 10:50 SESSION 1: Genetic heterogeneity of endocrine cancers
Chairs: Felix Beuschlein, Christine Spitzweg
09:00 – 09:45 Heterogeneity of thyroid cancer
James Fagin, USA
09:45 – 10:00 Discussion
10:00 – 10:30 Heterogeneity of neuroendocrine tumors
Justo Castagno, Spain
10:30 – 10:35 Discussion
10:35 – 10:50 Coffee break
10:50 – 12:35 SESSION 2: Molecular studies in endocrine cancer and their impact
for personalized therapy
Chairs: Martin Fassnacht, Barbara Jarząb
10:50 – 11:20 Advances in molecular understanding of thyroid cancer
Clara Alvarez, Santiago de Compostela, Spain
11:25 – 11:55 Molecular understanding of adrenal cancer in the clinical context of the disease
Guillaume Assie, France
12:00 – 12:30 Genetic testing beyond diagnosis in pheochromocytoma
and paraganglioma. The path to discovery of new genes, biomarkers and targets
Mercedes Robledo, Madrid, Spain
after each talk 5 minutes for discussion is provided
12:35 – 13:30 Lunch break
13:30 – 15:45 SESSION 3: Clinical issues in endocrine cancer
Chairs: Lionel Groussin, Anna Maria Colao
13:30 – 14:00 The necessity of multidisciplinary approaches for the research and treatment of NETs – a surgeons perspective
Massimo Falconi, Milan, Italy
14:05 – 14:35 Towards a new understanding and classification of aggressive pituitary tumors. Would it influence their management and treatment?
Gerald Raverot, Lyon, France
14:40 – 15:10 FIRST-MAPPP and beyond – perspectives in clinical studies for malignant pheochromocytoma
Eric Baudin, France
15:15 – 15:45 New ATA recommendation for differentiated thyroid cancer management from the point of view of European endocrinologist.
Furio Pacini, Siena, Italy
after each talk 5 minutes for discussion is provided
15:50 – 16:00 Summary and conclusions